Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#1315 Genes Involved in Angiogenesis and mTOR Are Frequently Found Mutated in Asian Patients with Pancreatic Neuroendocrine Tumors.

Introduction: There are limited data and inconsistent findings of genetic alteration in pancreatic neuroendocrine tumors (pNET).

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Wen-Chi C, Yi-Chen Y, Yi-Ming S, Yee C, Po-Han L,

Keywords: pancreatic NETs, gene mutation, mTOR,

#804 The Plasma Chromogranin A Level Predicts Survival and Tumor Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors

Introduction: The plasma chromogranin A (CgA) level is a reliable biomarker for identifying patients with advanced gastroenteropancreatic neuroendocrine tumors (GEP-NETs).

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author: Chou W

Authors: Chou W, Chen J, Hsu J, Chen T, Hung Y,

Keywords: neuroendocrine tumor, biomarker, chromogranin A,

#458 Octreotide Long-Acting ReleaseTherapy for Patients with Functional and Metastatic Gastroenteropancreatic Neuroendocrine Tumors: A Retrospective Analysis in Chang-Gung Memorial Hospital

Introduction: Reports of octreotide therapy for symptomatic control in patients with functioning gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in Asia are lacking.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Chia-Hsun H, Wen-Chi C, Yung-Chang L, Chaung-Chi L, Rong-Nan C,

Keywords: functioning gastroenteropancreatic neuroendocrine tumors, Octreotide LAR ,